{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:36:11Z","timestamp":1765456571279,"version":"3.46.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.braindev.2025.104390","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T21:23:50Z","timestamp":1751577830000},"page":"104390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A dilemma in pediatric migraine: Headache or school performance? \u2013 A comparison of topiramate and flunarizine"],"prefix":"10.1016","volume":"47","author":[{"given":"\u00dcnal","family":"Akca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fclfer","family":"Akca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eeyma","family":"Karatekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.braindev.2025.104390_bb0005","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1007\/s00415-024-12512-z","article-title":"Effectiveness and safety of pharmacological prophylaxis for chronic migraine: a systematic review and network meta-analysis","volume":"271","author":"Zhao","year":"2024","journal-title":"J Neurol"},{"key":"10.1016\/j.braindev.2025.104390_bb0010","series-title":"StatPearls","article-title":"Migraine Headache in Childhood","author":"Al Khalili","year":"2023"},{"issue":"3","key":"10.1016\/j.braindev.2025.104390_bb0015","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1212\/CON.0000000000000993","article-title":"Headache in Children and Adolescents","volume":"27","author":"Szperka","year":"2021","journal-title":"Continuum (Minneap Minn)"},{"issue":"1","key":"10.1016\/j.braindev.2025.104390_bb0020","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1542\/peds.2012-1909","article-title":"Incidence and risk factors of chronic daily headache in young adolescents: a school cohort study","volume":"132","author":"Lu","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.braindev.2025.104390_bb0025","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11910-010-0175-6","article-title":"Migraine chronification","volume":"11","author":"Bigal","year":"2011","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"Suppl. 1","key":"10.1016\/j.braindev.2025.104390_bb0030","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1007\/s10072-010-0264-y","article-title":"Pathophysiology of migraine chronification","volume":"31","author":"Aguggia","year":"2010","journal-title":"Neurol Sci"},{"issue":"9","key":"10.1016\/j.braindev.2025.104390_bb0035","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1007\/s12098-022-04279-w","article-title":"Effect of Propranolol Prophylaxis on Headache Frequency in Children with Migraine Without Aura: A Randomized, Double-Blind","volume":"90","author":"Keerthana","year":"2023","journal-title":"Placebo-Controlled Trial Indian J Pediatr"},{"issue":"18","key":"10.1016\/j.braindev.2025.104390_bb0040","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1212\/WNL.0b013e318271f812","article-title":"Migraine and migraine subtypes in preadolescent children: association with school performance","volume":"79","author":"Arruda","year":"2012","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.braindev.2025.104390_bb0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1136\/archdischild-2021-322373","article-title":"What is new in migraine management in children and young people?","volume":"107","author":"Loh","year":"2022","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.braindev.2025.104390_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s10194-024-01878-0","article-title":"Comparative efficacy and safety of different pharmacological therapies to medication overuse headache: a network meta-analysis","volume":"25","author":"Kong","year":"2024","journal-title":"J Headache Pain"},{"issue":"5","key":"10.1016\/j.braindev.2025.104390_bb0055","doi-asserted-by":"crossref","DOI":"10.1177\/03331024231178239","article-title":"Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition - An experience-based update","volume":"43","author":"Abu-Arafeh","year":"2023","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.braindev.2025.104390_bb0060","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jamapediatrics.2019.5856","article-title":"Efficacy, Safety, and Acceptability of Pharmacologic Treatments for Pediatric Migraine Prophylaxis: A Systematic Review and Network Meta-analysis","volume":"174","author":"Locher","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"11","key":"10.1016\/j.braindev.2025.104390_bb0065","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0000000000008105","article-title":"Practice guideline update summary: Pharmacologic treatment for pediatric migraine prevention","volume":"93","author":"Oskoui","year":"2019","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.braindev.2025.104390_bb0070","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11916-023-01157-8","article-title":"Advances in the Acute and Preventive Treatment of Pediatric Migraine","volume":"27","author":"Rastogi","year":"2023","journal-title":"Curr Pain Headache Rep"},{"issue":"1","key":"10.1016\/j.braindev.2025.104390_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.braindev.2025.104390_bb0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/clpt.1983.159","article-title":"Studies with different types of visual analog scales for measurement of pain","volume":"34","author":"Sriwatanakul","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.braindev.2025.104390_bb0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.sjpain.2016.06.012","article-title":"How to analyze the Visual Analogue Scale: Myths, truths and clinical relevance","volume":"13","author":"Heller","year":"2016","journal-title":"Scand J Pain"},{"issue":"5","key":"10.1016\/j.braindev.2025.104390_bb0090","first-page":"519","article-title":"Turkish version of the Pediatric Migraine Disability Assessment Score (PedMIDAS): reliability and validity","volume":"54","author":"Karli","year":"2012","journal-title":"Turk J Pediatr"},{"issue":"11","key":"10.1016\/j.braindev.2025.104390_bb0095","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1212\/WNL.57.11.2034","article-title":"PedMIDAS: development of a questionnaire to assess disability of migraines in children","volume":"57","author":"Hershey","year":"2001","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.braindev.2025.104390_bb0100","first-page":"24","article-title":"Pediatric Headache Management and Use of the PedMIDAS","volume":"12","author":"Livingston","year":"2019","journal-title":"J Dr Nurs Pract"},{"issue":"3","key":"10.1016\/j.braindev.2025.104390_bb0105","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1001\/jamapediatrics.2013.508","article-title":"Pharmacologic treatment of pediatric headaches: a meta-analysis","volume":"167","author":"El-Chammas","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.braindev.2025.104390_bb0110","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s10194-023-01594-1","article-title":"The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis","volume":"24","author":"Lampl","year":"2023","journal-title":"J Headache Pain"},{"issue":"12","key":"10.1016\/j.braindev.2025.104390_bb0115","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1212\/01.WNL.0000147332.41993.90","volume":"63","author":"Lewis","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.braindev.2025.104390_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002761","article-title":"Drugs for preventing migraine headaches in children","author":"Victor","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.braindev.2025.104390_bb0125","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pediatrneurol.2009.04.020","article-title":"Efficacy and tolerability of topiramate in pediatric migraine","volume":"41","author":"Cruz","year":"2009","journal-title":"Pediatr Neurol"},{"issue":"3","key":"10.1016\/j.braindev.2025.104390_bb0130","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.2008-0642","article-title":"Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age","volume":"123","author":"Lewis","year":"2009","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.braindev.2025.104390_bb0135","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/head.12699","article-title":"Prevention for Pediatric and Adolescent Migraine","volume":"55","author":"Hickman","year":"2015","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.braindev.2025.104390_bb0140","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/head.13025","article-title":"The Childhood and Adolescent Migraine Prevention (CHAMP) Study: \u201cWhat Do We Do Now?\u201d","volume":"57","author":"Powers","year":"2017","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.braindev.2025.104390_bb0145","doi-asserted-by":"crossref","DOI":"10.1111\/ped.15094","article-title":"Effects and side effects of migraine prophylaxis in children","volume":"64","author":"Tekin","year":"2022","journal-title":"Pediatr Int"},{"issue":"1","key":"10.1016\/j.braindev.2025.104390_bb0150","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s10194-023-01671-5","article-title":"European Headache Federation (EHF) critical reappraisal and meta-analysis of oral drugs in migraine prevention - part 3: topiramate","volume":"24","author":"Raffaelli","year":"2023","journal-title":"J Headache Pain"},{"issue":"08","key":"10.1016\/j.braindev.2025.104390_bb0155","first-page":"347","article-title":"A comparative study of the effectiveness of topiramate and flunarizine in independent series of chronic migraine patients without medication abuse","volume":"57","author":"Gracia-Naya","year":"2013","journal-title":"Rev Neurol"},{"issue":"8","key":"10.1016\/j.braindev.2025.104390_bb0160","doi-asserted-by":"crossref","first-page":"979","DOI":"10.4103\/njcp.njcp_199_17","article-title":"A survey on awareness, knowledge, and attitudes toward epilepsy in an urban community in Turkey","volume":"21","author":"Macit","year":"2018","journal-title":"Niger J Clin Pract"},{"issue":"3","key":"10.1016\/j.braindev.2025.104390_bb0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.yebeh.2007.06.010","article-title":"The differential effect of epilepsy labels on employer perceptions: report of a pilot study","author":"Bishop","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.braindev.2025.104390_bb0170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yebeh.2017.11.016","article-title":"Knowledge about epilepsy in university health students: A multicenter study","volume":"79","author":"Souza","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"Suppl. 2","key":"10.1016\/j.braindev.2025.104390_bb0175","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/03331024850050S227","article-title":"Flunarizine v. placebo in childhood migraine. A double-blind study","volume":"5","author":"Sorge","year":"1985","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.braindev.2025.104390_bb0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpn.2012.10.001","article-title":"Comparison of flunarizine and topiramate for the prophylaxis of pediatric migraines","volume":"17","author":"Kim","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"issue":"10","key":"10.1016\/j.braindev.2025.104390_bb0185","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.38666","article-title":"Preventive Medications in Pediatric Migraine: A Network Meta-Analysis","volume":"7","author":"Kohandel Gargari","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.braindev.2025.104390_bb0190","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s10194-023-01657-3","article-title":"European Headache Federation (EHF) critical re-appraisal and meta-analysis of oral drugs in migraine prevention-part 2: flunarizine","volume":"24","author":"Deligianni","year":"2023","journal-title":"J Headache Pain"},{"key":"10.1016\/j.braindev.2025.104390_bb0195","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0883073807304201","article-title":"Topiramate in theprophylaxis of pediatric migraine: A double-blind placebo-controlled trial","volume":"22","author":"Lakshmi","year":"2007","journal-title":"J Child Neurol"},{"issue":"11","key":"10.1016\/j.braindev.2025.104390_bb0200","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s12098-013-0976-0","article-title":"Topiramate and propranolol for prophylaxis of migraine","volume":"80","author":"Fallah","year":"2013","journal-title":"Indian J Pediatr"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425000725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760425000725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T12:32:52Z","timestamp":1765456372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760425000725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0387760425000725"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104390","relation":{},"ISSN":["0387-7604"],"issn-type":[{"type":"print","value":"0387-7604"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dilemma in pediatric migraine: Headache or school performance? \u2013 A comparison of topiramate and flunarizine","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2025.104390","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104390"}}